ARCHIVES

Faulding, NaPro In Agreement For Marketing Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

October issue of Business & Regulatory Report included.

November 5, 2004

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

October 30, 1998

Surgical Oncologists Certification Asked By SSO Workshop

December 9, 1983

In Brief: Susan O’Brien to move to UC Irvine Health

November 14, 2014

Latest U.S. cancer statistics cover 84% of population.

December 5, 2003

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002